| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
98,772 |
87,030 |
$4.72M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
90,152 |
80,710 |
$3.35M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
6,832 |
3,713 |
$3.22M |
| 99215 |
Prolong outpt/office vis |
4,775 |
4,251 |
$411K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,627 |
5,457 |
$364K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,642 |
5,353 |
$349K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,845 |
3,682 |
$334K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,237 |
2,971 |
$310K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,839 |
4,720 |
$310K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,941 |
7,229 |
$237K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,717 |
5,364 |
$233K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
4,856 |
3,556 |
$224K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,992 |
2,941 |
$210K |
| 80053 |
Comprehensive metabolic panel |
23,899 |
22,356 |
$199K |
| 64615 |
|
3,558 |
3,172 |
$189K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,131 |
1,745 |
$187K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,403 |
4,119 |
$180K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,628 |
2,534 |
$163K |
| 80061 |
Lipid panel |
16,061 |
15,485 |
$162K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,927 |
1,922 |
$161K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
679 |
599 |
$160K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,671 |
1,668 |
$159K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,137 |
1,722 |
$144K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,078 |
9,372 |
$141K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,790 |
1,077 |
$136K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
24,006 |
18,844 |
$132K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,693 |
18,972 |
$128K |
| 90686 |
|
11,875 |
11,254 |
$112K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,216 |
7,926 |
$104K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,707 |
1,652 |
$102K |
| 3008F |
|
11,631 |
10,963 |
$100K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
599 |
537 |
$93K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,386 |
1,851 |
$92K |
| 80050 |
General health panel |
1,960 |
1,819 |
$88K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
11,944 |
11,520 |
$85K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,107 |
1,946 |
$85K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,186 |
1,934 |
$85K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,751 |
15,249 |
$81K |
| 90677 |
|
1,083 |
1,042 |
$75K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,958 |
1,827 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
57,317 |
51,960 |
$73K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,034 |
1,868 |
$72K |
| 71046 |
Radiologic examination, chest; 2 views |
6,341 |
5,898 |
$71K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
561 |
557 |
$65K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,222 |
6,066 |
$57K |
| 0002A |
|
1,663 |
1,545 |
$57K |
| 0001A |
|
1,816 |
1,687 |
$56K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
290 |
259 |
$56K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
190 |
158 |
$52K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,522 |
893 |
$50K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,203 |
3,350 |
$50K |
| 73221 |
|
238 |
209 |
$47K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,593 |
1,458 |
$45K |
| 0240U |
|
1,397 |
1,309 |
$43K |
| 95886 |
|
720 |
648 |
$43K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
309 |
277 |
$41K |
| 99221 |
|
899 |
825 |
$37K |
| 76820 |
|
1,022 |
605 |
$36K |
| 99205 |
Prolong outpt/office vis |
298 |
289 |
$35K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
533 |
413 |
$35K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
278 |
264 |
$34K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,048 |
967 |
$33K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
155 |
136 |
$32K |
| 97161 |
|
578 |
577 |
$31K |
| 81001 |
|
11,776 |
10,842 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,440 |
4,092 |
$30K |
| 73630 |
|
1,830 |
1,606 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,940 |
1,216 |
$26K |
| 73564 |
|
1,283 |
1,172 |
$24K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,681 |
1,632 |
$24K |
| 81025 |
|
3,084 |
2,932 |
$23K |
| 20553 |
|
1,714 |
914 |
$22K |
| 87210 |
|
3,967 |
3,752 |
$20K |
| 0124A |
|
584 |
562 |
$19K |
| 73610 |
|
1,363 |
1,156 |
$19K |
| 87428 |
|
618 |
520 |
$19K |
| 97597 |
|
1,235 |
729 |
$18K |
| 72100 |
|
1,008 |
943 |
$18K |
| 0071A |
|
650 |
497 |
$18K |
| 74018 |
|
1,649 |
1,528 |
$18K |
| 92567 |
|
1,422 |
1,291 |
$17K |
| 0004A |
|
548 |
471 |
$17K |
| 76825 |
|
149 |
131 |
$17K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
663 |
584 |
$16K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
131 |
131 |
$15K |
| 90651 |
|
867 |
842 |
$15K |
| 85027 |
|
2,769 |
2,685 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,992 |
1,745 |
$14K |
| 73130 |
|
882 |
769 |
$14K |
| 0072A |
|
508 |
387 |
$13K |
| 73030 |
|
1,037 |
931 |
$13K |
| 90672 |
|
620 |
598 |
$13K |
| 93325 |
|
438 |
365 |
$12K |
| 73110 |
|
807 |
705 |
$12K |
| 0054A |
|
400 |
342 |
$12K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
28 |
28 |
$11K |
| 90670 |
|
2,709 |
2,663 |
$11K |
| 97162 |
|
216 |
213 |
$11K |
| 90723 |
|
2,283 |
2,245 |
$11K |
| 90656 |
|
749 |
743 |
$10K |
| 86140 |
|
2,436 |
2,339 |
$10K |
| 90647 |
|
2,126 |
2,082 |
$9K |
| 43248 |
|
129 |
110 |
$9K |
| 95806 |
|
240 |
223 |
$9K |
| 0064A |
|
225 |
209 |
$8K |
| 0031A |
|
238 |
228 |
$8K |
| 90680 |
|
1,565 |
1,539 |
$7K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
71 |
70 |
$7K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
217 |
202 |
$7K |
| 73140 |
|
573 |
495 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
34 |
29 |
$6K |
| 73620 |
|
507 |
343 |
$6K |
| 82043 |
|
1,347 |
1,318 |
$6K |
| 0011A |
|
144 |
144 |
$6K |
| 90746 |
|
81 |
79 |
$6K |
| 82570 |
|
1,413 |
1,374 |
$5K |
| 90715 |
|
478 |
458 |
$5K |
| 73560 |
|
381 |
335 |
$5K |
| V5266 |
Battery for use in hearing device |
518 |
443 |
$5K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
357 |
346 |
$5K |
| 83735 |
|
912 |
825 |
$5K |
| 93244 |
|
413 |
389 |
$5K |
| 0134A |
|
146 |
146 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,360 |
1,320 |
$5K |
| 91320 |
|
49 |
43 |
$5K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$5K |
| 0012A |
|
126 |
125 |
$5K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
144 |
126 |
$4K |
| 90474 |
|
700 |
695 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
118 |
39 |
$4K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
15 |
14 |
$4K |
| 85018 |
|
1,737 |
1,651 |
$4K |
| 90961 |
|
165 |
118 |
$4K |
| 83690 |
|
655 |
616 |
$4K |
| 95251 |
|
292 |
268 |
$3K |
| 74019 |
|
278 |
247 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
85 |
75 |
$3K |
| 99442 |
|
209 |
187 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
178 |
99 |
$3K |
| 72141 |
|
14 |
13 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,646 |
3,421 |
$3K |
| 76830 |
Ultrasound, transvaginal |
52 |
51 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
94 |
63 |
$3K |
| 76826 |
|
37 |
32 |
$3K |
| 95874 |
|
371 |
300 |
$3K |
| 17110 |
|
43 |
42 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
225 |
89 |
$3K |
| 92557 |
|
113 |
99 |
$3K |
| 87807 |
|
246 |
231 |
$3K |
| 90732 |
|
26 |
26 |
$3K |
| 85014 |
|
1,152 |
1,068 |
$2K |
| 90633 |
|
826 |
822 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
113 |
56 |
$2K |
| 73562 |
|
179 |
151 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
15 |
12 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
62 |
62 |
$2K |
| 90734 |
|
651 |
630 |
$2K |
| 85651 |
|
642 |
610 |
$2K |
| 73600 |
|
179 |
150 |
$2K |
| 95012 |
|
181 |
159 |
$2K |
| 95908 |
|
33 |
28 |
$2K |
| 82728 |
|
172 |
159 |
$2K |
| 0052A |
|
67 |
53 |
$2K |
| 93971 |
|
139 |
125 |
$2K |
| 90970 |
|
1,232 |
44 |
$2K |
| 36416 |
|
950 |
770 |
$2K |
| 80305 |
|
149 |
144 |
$2K |
| 73503 |
|
90 |
83 |
$2K |
| 99241 |
|
54 |
47 |
$2K |
| 64644 |
|
28 |
25 |
$1K |
| 99493 |
|
12 |
12 |
$1K |
| 90480 |
|
46 |
44 |
$1K |
| 99495 |
|
12 |
12 |
$1K |
| 99310 |
Prolong nursin fac eval 15m |
13 |
12 |
$1K |
| 96127 |
|
443 |
413 |
$1K |
| 76801 |
|
16 |
15 |
$1K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
17 |
12 |
$1K |
| 99460 |
|
12 |
12 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
41 |
15 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
95 |
82 |
$1K |
| 93294 |
|
219 |
175 |
$1K |
| 11721 |
|
104 |
98 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,621 |
864 |
$1K |
| 76827 |
|
18 |
18 |
$1K |
| 71101 |
|
66 |
62 |
$998.54 |
| 43235 |
|
16 |
12 |
$994.13 |
| 76828 |
|
19 |
17 |
$947.92 |
| 72040 |
|
54 |
52 |
$942.52 |
| 93295 |
|
70 |
56 |
$929.23 |
| 99441 |
|
111 |
106 |
$906.49 |
| 99152 |
|
59 |
42 |
$904.04 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
35 |
34 |
$899.52 |
| 73502 |
|
62 |
57 |
$897.51 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
54 |
32 |
$891.61 |
| 76813 |
|
15 |
14 |
$875.69 |
| 90962 |
|
28 |
13 |
$829.36 |
| 73070 |
|
53 |
50 |
$816.40 |
| 90671 |
|
59 |
57 |
$802.50 |
| 99243 |
|
12 |
12 |
$764.83 |
| 99381 |
|
13 |
13 |
$716.18 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
299 |
262 |
$699.90 |
| 99223 |
Prolong inpt eval add15 m |
15 |
12 |
$688.14 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
36 |
27 |
$682.91 |
| 85610 |
|
223 |
145 |
$599.36 |
| A9573 |
Injection, gadopiclenol, 1 ml |
49 |
37 |
$538.03 |
| 93320 |
|
17 |
12 |
$522.64 |
| 0034A |
|
18 |
14 |
$457.92 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
17 |
12 |
$455.65 |
| 94060 |
|
54 |
47 |
$448.73 |
| 90660 |
|
27 |
27 |
$444.37 |
| 90674 |
|
122 |
121 |
$423.60 |
| V5014 |
Repair/modification of a hearing aid |
23 |
14 |
$409.28 |
| 95117 |
|
94 |
66 |
$382.11 |
| 84484 |
|
39 |
38 |
$355.47 |
| 94010 |
|
15 |
13 |
$354.67 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17 |
14 |
$354.20 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
12 |
$350.90 |
| Q3014 |
Telehealth originating site facility fee |
14 |
13 |
$327.66 |
| 20552 |
|
27 |
13 |
$288.22 |
| 90716 |
|
182 |
182 |
$280.54 |
| 93242 |
|
39 |
38 |
$273.74 |
| 94726 |
|
39 |
34 |
$262.31 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
16 |
$245.63 |
| 99443 |
|
12 |
12 |
$244.38 |
| 94729 |
|
65 |
56 |
$235.81 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
32 |
30 |
$219.61 |
| 72070 |
|
12 |
12 |
$209.81 |
| 69210 |
|
33 |
28 |
$206.17 |
| 80076 |
|
27 |
26 |
$202.00 |
| 73590 |
|
13 |
12 |
$188.76 |
| 87081 |
|
38 |
33 |
$177.76 |
| 83655 |
|
16 |
14 |
$169.90 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
109 |
94 |
$160.86 |
| 82947 |
|
38 |
37 |
$125.93 |
| 85379 |
|
12 |
12 |
$112.29 |
| 3044F |
|
6,486 |
5,302 |
$100.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
49 |
47 |
$98.99 |
| 82565 |
|
32 |
28 |
$95.41 |
| 81003 |
|
47 |
41 |
$89.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
107 |
106 |
$88.76 |
| 90707 |
|
218 |
218 |
$77.16 |
| 93018 |
|
13 |
13 |
$56.00 |
| 90688 |
|
21 |
17 |
$52.96 |
| 82950 |
|
13 |
13 |
$52.25 |
| 99421 |
|
30 |
25 |
$46.80 |
| 84550 |
|
12 |
12 |
$44.38 |
| 90710 |
|
12 |
12 |
$39.82 |
| 90696 |
|
39 |
39 |
$39.82 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
232 |
177 |
$32.09 |
| 0298T |
|
15 |
14 |
$10.70 |
| G0008 |
Administration of influenza virus vaccine |
26 |
26 |
$7.00 |
| 3078F |
|
107,927 |
97,232 |
$0.27 |
| 3074F |
|
118,147 |
105,956 |
$0.23 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,885 |
2,409 |
$0.06 |
| 3075F |
|
7,718 |
7,186 |
$0.05 |
| 4010F |
|
11,926 |
9,708 |
$0.03 |
| 3077F |
|
2,664 |
2,468 |
$0.01 |
| 3079F |
|
15,321 |
13,861 |
$0.01 |
| 3080F |
|
1,558 |
1,468 |
$0.01 |
| 91312 |
|
487 |
470 |
$0.00 |
| 91300 |
|
4,230 |
3,651 |
$0.00 |
| 1160F |
|
925 |
818 |
$0.00 |
| 3050F |
|
2,897 |
2,345 |
$0.00 |
| 1159F |
|
1,047 |
913 |
$0.00 |
| 3046F |
|
509 |
381 |
$0.00 |
| 3051F |
|
679 |
540 |
$0.00 |
| 97602 |
|
83 |
56 |
$0.00 |
| 90700 |
|
49 |
49 |
$0.00 |
| 91313 |
|
133 |
133 |
$0.00 |
| 90473 |
|
198 |
181 |
$0.00 |
| 3062F |
|
15 |
13 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
18 |
14 |
$0.00 |
| 3048F |
|
11,125 |
9,016 |
$0.00 |
| 3049F |
|
3,854 |
3,084 |
$0.00 |
| 1126F |
|
500 |
475 |
$0.00 |
| 3061F |
|
1,455 |
1,196 |
$0.00 |
| 91303 |
|
266 |
247 |
$0.00 |
| 1125F |
|
364 |
339 |
$0.00 |
| 3060F |
|
401 |
321 |
$0.00 |
| 91306 |
|
224 |
210 |
$0.00 |
| 91305 |
|
623 |
541 |
$0.00 |
| 91307 |
|
1,231 |
882 |
$0.00 |
| 91301 |
|
354 |
342 |
$0.00 |
| 1157F |
|
125 |
112 |
$0.00 |
| 1111F |
|
74 |
60 |
$0.00 |
| 3052F |
|
146 |
116 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
31 |
15 |
$0.00 |
| 99406 |
|
13 |
12 |
$0.00 |
| J3490 |
Unclassified drugs |
29 |
14 |
$0.00 |